Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Kwality Pharmaceuticals reported a strong second quarter for fiscal 2027, with consolidated revenue rising 63% year on year to INR 181 crore from INR 111 crore a year earlier and profit after tax doubling to INR 50 crore. Despite the strong earnings growth, an InvestingPro analysis reveals the stock is trading at a low P/E ratio relative to near-term earnings growth, one of 10 key ProTips available to subscribers.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
